LDL Receptor antibody | knockout validation | Abcam ab52818

This is a knockout-validated antibody summary, based on the publications "Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death", as cited below [1], and "Genome-scale CRISPR screening for modifiers of cellular LDL uptake" for western blot knockout validation (figure 4b) [2]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Antibody information

Rabbit monoclonal IgG

Company: Abcam

Antibody: LDL Receptor

Catalog number: ab52818

Summary: Rabbit monoclonal IgG against a synthetic peptide within Human LDL Receptor (aa 800 to the C-terminus). Reacts with mouse and human. Suitable for western blot and immunohistochemistry (paraffin).

Validation Method

Western blot

Sample

Control and LDLR-KO Karpas299 cells. Cells were lysed in buffer (10 mM Tris-Cl pH 7.5, 150 NaCl, 1 mM EDTA, 1% Triton X-100, 2% SDS, CHAPS 0.1%) supplemented with protease inhibitors and PhosSTOP (Roche).

Secondary incubation

HRP-conjugated anti-rabbit antibody (Santa Cruz).

Figure

Immunoblots for LDLR and SQLE in control and SQLE cDNA expressing Karpas299 cells infected with sgAAVS1 or sgLDLR1 virus in the presence or absence of Shield-1 (250 nM). Please see Ext. Figure 4e in the article [1].

References
  1. Garcia Bermudez J, Baudrier L, Bayraktar E, Shen Y, La K, Guarecuco R, et al. Squalene accumulation in cholesterol auxotrophic lymphomas prevents oxidative cell death. Nature. 2019;567:118-122 pubmed publisher
  2. Emmer B, Sherman E, Lascuna P, Graham S, Willer C, Ginsburg D. Genome-scale CRISPR screening for modifiers of cellular LDL uptake. PLoS Genet. 2021;17:e1009285 pubmed publisher